---
title: "RXO, Inc. Stock 12‑Month Price Target Raised to $21.53, Implies 25% Downside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289447715.md"
description: "Analysts have raised the 12-month average price target for RXO, Inc. to $21.53 from $21.27, based on estimates from 15 analysts. Despite this increase, the new target implies a 25% downside from the June 10 closing price. The consensus rating remains 'Hold' among 19 covering analysts, comprising 5 Buys, 12 Holds, and 2 Sells."
datetime: "2026-06-11T10:20:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289447715.md)
  - [en](https://longbridge.com/en/news/289447715.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289447715.md)
---

# RXO, Inc. Stock 12‑Month Price Target Raised to $21.53, Implies 25% Downside

-   According to estimates from 15 analysts, RXO, Inc. stock's average price target has risen from $21.27 to $21.53, with forecasts ranging from $13 to $29 per share
-   Based on the Jun. 10 closing price, the updated target implies approximately 25% potential downside
-   Consensus rating remains at “Hold” across 19 covering analysts, with 5 Buys, 12 Holds and 2 Sells

Explore more price target data and ratings for RXO, Inc. on the , and track all previous and future analyst recommendations for RXO, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [RXO.US](https://longbridge.com/en/quote/RXO.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [3 Reasons Why Unusual Options Activity in Progressive Stock May Point to a Bottom](https://longbridge.com/en/news/288755797.md)
- [This Analyst Just Upgraded Chipotle Stock. Here's Why.](https://longbridge.com/en/news/289079873.md)
- [A Look At Wintrust Financial (WTFC) Valuation As Shares Show Recent Positive Momentum](https://longbridge.com/en/news/289517198.md)
- [10x Genomics (TXG) Stock Valuation After Recent Surge In Returns](https://longbridge.com/en/news/289661443.md)
- [Assessing Jacobs Solutions (J) Valuation As Share Momentum Softens And Backlog Growth Supports Outlook](https://longbridge.com/en/news/289239890.md)